Medicare Enrolled
Dr. Adam Mamelak, M.D.
MOHS-Micrographic Surgery Physician · Austin, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mamelak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mamelak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mamelak
Dr. Adam Mamelak is a mohs-micrographic surgery physician in Austin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mamelak performed 3,153 Medicare services across 1,860 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mamelak received a total of $6,404 from 46 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mamelak is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in TX
$6,404 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,153
Medicare services
Top 34% in TX for mohs-micrographic surgery physician
1,860
Unique beneficiaries
$125
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~166 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
888 | $5 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $68 | $184 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
308 | $42 | $116 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
281 | $460 | $1,412 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
241 | $38 | $140 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
149 | $62 | $214 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
127 | $78 | $239 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
122 | $194 | $981 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
116 | $203 | $887 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
107 | $476 | $1,326 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 103 | $338 | $860 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
40 | $41 | $106 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $85 | $228 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $93 | $260 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
32 | $238 | $830 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
30 | $136 | $353 |
| Skin graft repair of eyelid, nose, ear, or lip, 10 sq cm or less A surgical procedure to repair a wound on the eyelid, nose, ear, or lip by transferring a small piece of skin. The transferred skin covers an area of 10 square centimeters or less. |
27 | $594 | $1,579 |
| Complex repair of eyelid, nose, ear, or lip wound, 2.6-7.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 2.6 and 7.5 centimeters. |
24 | $202 | $1,030 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
22 | $100 | $510 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
18 | $1 | $2 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
15 | $39 | $119 |
| Complex wound repair, 1.1-2.5 cm A surgical procedure to close a complex wound measuring between 1.1 and 2.5 centimeters on areas such as the face, neck, hands, or feet. |
14 | $159 | $807 |
| Complex repair of eyelid, nose, ear, or lip wound, 1.1-2.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 1.1 and 2.5 centimeters. |
13 | $186 | $879 |
| Skin graft repair, 10.1-30 sq cm A surgical procedure to repair wounds on the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin. The graft covers an area between 10.1 and 30.0 square centimeters. |
11 | $712 | $1,892 |
| Additional Mohs surgery stage with microscopic exam This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth. |
11 | $324 | $826 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
7.0% medium
92.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,404
Total received (2018-2024)
Avg $915/year across 7 years
Top 29% in TX for mohs-micrographic surgery physician
46
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,264 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$140 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,381
2023
$923
2022
$732
2021
$335
2020
$427
2019
$1,365
2018
$1,240
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Galderma Laboratories, L.P.
$568
ABBVIE INC.
$546
Novartis Pharmaceuticals Corporation
$476
VYNE Pharmaceuticals Inc.
$363
Janssen Biotech, Inc.
$361
Regeneron Healthcare Solutions, Inc.
$340
AbbVie, Inc.
$297
E.R. Squibb & Sons, L.L.C.
$291
UCB, Inc.
$273
GENZYME CORPORATION
$270
PFIZER INC.
$261
LEO Pharma Inc.
$226
Amgen Inc.
$220
Kerecis Limited
$140
Genentech USA, Inc.
$140
Lilly USA, LLC
$136
Ortho Dermatologics, a division of Bausch Health US, LLC
$127
Almirall LLC
$120
Misonix Inc
$115
Journey Medical Corporation
$114
Sun Pharmaceutical Industries Inc.
$89
Mayne Pharma Inc.
$79
ConvaTec Inc.
$76
Incyte Corporation
$59
Biofrontera Inc.
$54
Allergan, Inc.
$50
Arcutis Biotherapeutics, Inc.
$49
MIMEDX Group, Inc.
$47
Encore Dermatology Inc.
$43
PruGen, Inc. Pharmaceuticals
$42
Organogenesis Inc.
$42
Boston Scientific Corporation
$42
EPI Health, LLC
$41
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
Promius Pharma LLC
$36
Merz North America, Inc.
$35
TRIAD LIFE SCIENCES INC.
$31
Celgene Corporation
$30
DUSA Pharmaceuticals, Inc.
$22
Aclaris Therapeutics, Inc.
$21
AbbVie Inc.
$19
Abbott Laboratories
$18
Mylan Pharmaceuticals Inc.
$17
Medtronic, Inc.
$16
Dermavant Sciences, Inc.
$14
Taro Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 24.8% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ADBRY · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · BOTOX · Bensal HP · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DERMATITIS - DISEASE · DISEASE STATE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · Exelderm · General - DBS · HUMIRA · Humira · ILUMYA · INNOVAMATRIX AC · Impoyz · Kerecis Omega3 SurgiClose · LEVULAN KERASTICK · LIBTAYO · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · PERCEPT PC BRAINSENSE · PROCLAIM · Puraply · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SKYRIZI · SOOLANTRA · Sernivo Spray · Seysara · Sitavig · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · VTAMA · Veltin · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $203 per 100 Medicare services performed
Geographic Context
Mohs-micrographic surgery physicians within 10 mi
12
Per 100K population
0.9
County median income
$97,169
Nearest hospital
NORTH AUSTIN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mamelak is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mamelak experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mamelak performed 888 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mamelak receive payments from pharmaceutical companies?
Yes. Dr. Mamelak received a total of $6,404 from 46 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mamelak's costs compare to other mohs-micrographic surgery physicians in Austin?
Dr. Mamelak's average Medicare payment per service is $125. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mamelak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in Austin
Browse mohs-micrographic surgery physicians in Austin ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in TX
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in TX
Which TX mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology